BOOTHBAY FUND MANAGEMENT, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1549230 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,065,164

-$231,122 QoQ

Shares Held

3,312

+11.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#511

of 1,322 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. REGN ranks #65 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	465,787	$87,232,589
2	ABVX	Abivax S.A.	563,367	$75,074,286
3	EXEL	Exelixis, Inc.	804,095	$43,750,808
4	PCVX	Vaxcyte, Inc.	534,163	$31,050,895
5	COGT	Cogent Biosciences, Inc.	692,825	$26,812,327
6	CGEM	Cullinan Therapeutics, Inc.	1,082,611	$19,714,346
7	TNGX	Tango Therapeutics, Inc.	500,497	$15,645,536
8	AVTX	Avalo Therapeutics, Inc.	702,051	$12,973,902

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,065,164	3,312	+11.4%	Shares	Other	2026-08-14
2026-03-31	$2,296,286	2,972	-29.9%	Shares	Other	2026-05-15
2025-09-30	$2,384,024	4,240	+57.1%	Shares	Other	2025-11-14
2025-06-30	$1,416,975	2,699	-78.2%	Shares	Other	2025-08-14
2024-12-31	$8,815,083	12,375	+989.3%	Shares	Other	2025-02-14
2024-09-30	$1,194,208	1,136	-77.6%	Shares	Other	2024-11-14
2024-03-31	$4,890,411	5,081	-52.0%	Shares	Other	2024-05-15
2023-06-30	$7,609,338	10,590	+2809.3%	Shares	Other	2023-08-14
2023-03-31	$299,087	364	+28.2%	Shares	Other	2023-05-15
2022-12-31	$204,903	284	-92.9%	Shares	Other	2023-02-14
2020-06-30	$2,494,600	4,000	-20.0%	Shares	Other	2020-08-14
2020-03-31	$2,441,450	5,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.